Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Teva Pharmaceutical: Predictable Growth, Good Value
Seeking Alpha
Thursday, August 20, 2009 - 7:17am
tags:
Teva Pharmaceuticals, Forest Labs, Mylan, Watson Pharmaceuticals, Impax Labs
Why Pharma Wants ObamaCare: There are reasons it could be good for drug companies--and they're not what you think
Forbes
Thursday, August 20, 2009 - 7:16am
tags:
healthcare reform
Pfizer will make clinical trial networking site
Pfizer
Thursday, August 20, 2009 - 6:19am
tags:
drug trials, clinical trials, Pfizer
Tough Decisions on Osteoporosis Drugs
Businessweek
Thursday, August 20, 2009 - 6:18am
tags:
osteoporosis, Amgen, Eli Lilly, denosumab, arzoxifene, FDA
Vaccine Surprise Redeems AstraZeneca’s MedImmmune Buy
Bloomberg
Thursday, August 20, 2009 - 6:17am
tags:
vaccines, AstraZeneca, MedImmune, M&A, swine flu, H1N1
Disclosure trend hits PBM-drugmaker deals
Fierce Pharma
Wednesday, August 19, 2009 - 6:39pm
tags:
PBMs
AVI BioPharma says it intends to launch public offering of company shares
Yahoo/AP
Wednesday, August 19, 2009 - 6:38pm
tags:
AVI BioPharma, stock offering
Biotech Stock Mailbag: Geron, Oculus, BioSante
TheStreet.com
Wednesday, August 19, 2009 - 3:54pm
tags:
Geron, Oculus Innovative Sciences, BioSante
Panel Decision to Benefit J&J
Yahoo/Zacks.com
Wednesday, August 19, 2009 - 3:53pm
tags:
Panel, JNJ, hip replacements
Amgen's Climbing Up the Ladder
Motley Fool
Wednesday, August 19, 2009 - 3:49pm
tags:
Amgen, Vectibix, Sanofi, Pfizer, Bristol-Myers Squibb, Eli Lilly, colon cancer
Mylan's HIV Drug Gets Tentative OK
Yahoo/Zacks.com
Wednesday, August 19, 2009 - 12:23pm
tags:
HIV, FDA, Mylan, Gilead Sciences
Merck Singulair patent upheld in Teva case
Marketwatch
Wednesday, August 19, 2009 - 12:05pm
tags:
Merck, Teva Pharmaceuticals, Singulair, patents
Drug stocks mixed; Lilly falls on drug setback
Marketwatch
Wednesday, August 19, 2009 - 9:59am
tags:
drug stocks, Eli Lilly
Eastern Europe drug market worth $41bn by 2014; but rules complex
In-Pharma Technologist
Wednesday, August 19, 2009 - 9:50am
tags:
Europe
CSL Expects Profit to Rise on Plasma Sales, Swine Flu Vaccine
Bloomberg
Wednesday, August 19, 2009 - 9:45am
tags:
CSL, earnings, swine flu, vaccines, H1N1
[video] Risk-Reward Favors Xoma
TheStreet.com
Wednesday, August 19, 2009 - 9:36am
tags:
Xoma
FDA Sends J&J Warning Letter Over Trial Conditions
Pharma Live
Wednesday, August 19, 2009 - 9:32am
tags:
JNJ, FDA, warnings
Why I'm Buying Protalix
Seeking Alpha
Wednesday, August 19, 2009 - 9:31am
tags:
Protalix BioTherapeutics, Genzyme, Gaucher disease
Forest's lung disease drug fails mid-stage trial
Yahoo/AP
Wednesday, August 19, 2009 - 8:27am
tags:
Forest Labs, lung disease, drug trials, oglemilast
Bristol-Myers $125 Million Plavix Accord Tentatively Approved
Bloomberg
Wednesday, August 19, 2009 - 7:42am
tags:
Bristol-Myers Squibb, Plavix, patents, Apotex

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.